Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
2026
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.23M | ﹤0.01% |
319,450
+15,174
| +5% | +$361K |
|
|
ILPT
2027
Industrial Logistics Properties Trust
ILPT
$611M
| $9.2M | ﹤0.01% |
1,956,855
-148,966
| -7% | -$483K |
|
2028
Trupanion
TRUP
$1.36B
| $9.15M | ﹤0.01% |
300,029
+7,088
| +2% | +$188K |
|
|
RYZB
2029
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $9.15M | ﹤0.01% |
+147,140
| New | +$3.66M |
|
|
RDFN
2030
DELISTED
Redfin
RDFN
| $9.14M | ﹤0.01% |
885,705
+29,618
| +3% | +$206K |
|
2031
Magnite
MGNI
$3.53B
| $9.11M | ﹤0.01% |
975,662
+16,062
| +2% | +$127K |
|
2032
Victory Capital Holdings
VCTR
$7.27B
| $9.11M | ﹤0.01% |
264,459
-8,889
| -3% | -$284K |
|
|
TUP
2033
DELISTED
Tupperware Brands Corporation
TUP
| $9.1M | ﹤0.01% |
4,550,537
+704,700
| +18% | +$1.28M |
|
2034
Levi Strauss
LEVI
$8.63B
| $9.07M | ﹤0.01% |
548,183
+10,020
| +2% | +$149K |
|
|
FBRT
2035
Franklin BSP Realty Trust
FBRT
$675M
| $9.06M | ﹤0.01% |
670,299
+11,998
| +2% | +$158K |
|
|
SLCA
2036
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $9.05M | ﹤0.01% |
800,562
-2,697
| -0.3% | -$32K |
|
|
VTLE
2037
DELISTED
Vital Energy
VTLE
| $9.04M | ﹤0.01% |
198,772
+64,881
| +48% | +$3.11M |
|
2038
Teekay Tankers
TNK
$2.9B
| $9.03M | ﹤0.01% |
180,733
-14,025
| -7% | -$674K |
|
|
EVBG
2039
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $9.03M | ﹤0.01% |
371,278
+2,770
| +0.8% | +$59.7K |
|
2040
Arlo Technologies
ARLO
$1.54B
| $9.03M | ﹤0.01% |
948,042
+58,620
| +7% | +$535K |
|
2041
LeMaitre Vascular
LMAT
$1.87B
| $9.02M | ﹤0.01% |
158,947
-1,109
| -0.7% | -$58.1K |
|
2042
Arcus Biosciences
RCUS
$3.67B
| $9.02M | ﹤0.01% |
472,182
+11,341
| +2% | +$181K |
|
2043
Comstock Resources
CRK
$3.99B
| $8.99M | ﹤0.01% |
1,015,403
+93,140
| +10% | +$1.01M |
|
|
BBT
2044
Beacon Financial Corp
BBT
$2.71B
| $8.99M | ﹤0.01% |
361,890
+6,624
| +2% | +$143K |
|
|
SAGE
2045
DELISTED
Sage Therapeutics
SAGE
| $8.97M | ﹤0.01% |
413,905
+4,918
| +1% | +$97.5K |
|
2046
Intapp
INTA
$3.16B
| $8.96M | ﹤0.01% |
235,629
+45,254
| +24% | +$1.67M |
|
2047
Peoples Bancorp
PEBO
$1.49B
| $8.95M | ﹤0.01% |
265,064
+6,824
| +3% | +$199K |
|
|
ROVR
2048
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $8.9M | ﹤0.01% |
818,022
-451
| -0.1% | -$3.81K |
|
|
AY
2049
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $8.9M | ﹤0.01% |
413,922
+53,862
| +15% | +$1.02M |
|
2050
iShares MSCI EAFE ETF
EFA
$80.3B
| $8.89M | ﹤0.01% |
118,023
+48,605
| +70% | +$3.44M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.